|
3
|
21
|
1k3mA |
Nmr structure of human insulin mutant ile-a2-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 15 structures |
|
4
|
36
|
1fvnA |
[ala31, aib32]-neuropeptide y |
|
1
|
29
|
1iohB |
Insulin mutant a8 his,(b1, b10, b16, b27)glu, des-b30, nmr, 26 structures |
|
5
|
32
|
1byvA |
Glycosylated eel calcitonin |
|
17
|
78
|
1j0tA |
The solution structure of molt-inhibiting hormone from the kuruma prawn |
|
10
|
107
|
1ks6A |
Transforming growth factor beta type ii receptor ligand binding domain |
|
3
|
30
|
1kmfB |
Nmr structure of human insulin mutant ile-a2-allo-ile, his-b10-asp, pro-b28-lys, lys-b29-pro, 15 structures |
|
6
|
55
|
1kmxA |
Heparin-binding domain from vascular endothelial growth factor |
|
3
|
32
|
1k4uP |
Solution structure of the c-terminal sh3 domain of p67phox complexed with the c-terminal tail region of p47phox |
|
12
|
30
|
1d0rA |
Solution structure of glucagon-like peptide-1-(7-36)-amide in trifluoroethanol/water |
|
1
|
25
|
1bqfA |
Growth-blocking peptide (gbp) from pseudaletia separata |
|
2
|
29
|
1iogB |
Insulin mutant a3 gly,(b1, b10, b16, b27)glu, des-b30, nmr, 19 structures |
|
2
|
21
|
1iohA |
Insulin mutant a8 his,(b1, b10, b16, b27)glu, des-b30, nmr, 26 structures |
|
18
|
92
|
1l5cA |
Solution structure of the monomeric form of a mutant unliganded bovine neurophysin, 20 structures |
|
38
|
168
|
1bu9A |
Solution structure of p18-ink4c, 21 structures |
|
1
|
29
|
1kx6A |
Nmr solution structure of glucagon in a lipid-water interphase |
|
0
|
10
|
1kuwA |
High-resolution structure and localization of amylin nucleation site in detergent micelles |
|
7
|
31
|
1fvyA |
Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone |
|
1
|
10
|
1c9aA |
Solution structure of neuromedin b |
|
3
|
30
|
1ho0A |
New b-chain mutant of bovine insulin |
|
2
|
21
|
1iogA |
Insulin mutant a3 gly,(b1, b10, b16, b27)glu, des-b30, nmr, 19 structures |
|
15
|
108
|
1k0xA |
Solution structure of melanoma inhibitory activity protein |
|
3
|
30
|
1jcoB |
Solution structure of the monomeric [thr(b27)->pro,pro(b28)->thr] insulin mutant (pt insulin) |
|
6
|
36
|
1icyA |
[ala31,pro32]-pnpy bound to dpc micelles |
|
4
|
30
|
1k3mB |
Nmr structure of human insulin mutant ile-a2-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 15 structures |
|
4
|
46
|
1k36A |
Nmr structure of human epiregulin |
|
5
|
62
|
1k4uS |
Solution structure of the c-terminal sh3 domain of p67phox complexed with the c-terminal tail region of p47phox |
|
9
|
60
|
1efeA |
An active mini-proinsulin, m2pi |
|
6
|
50
|
1ioxA |
Nmr structure of human betacellulin-2 |
|
4
|
21
|
1kmfA |
Nmr structure of human insulin mutant ile-a2-allo-ile, his-b10-asp, pro-b28-lys, lys-b29-pro, 15 structures |
|
3
|
21
|
1jcoA |
Solution structure of the monomeric [thr(b27)->pro,pro(b28)->thr] insulin mutant (pt insulin) |
|
3
|
46
|
1boeA |
Structure of the igf binding domain of the insulin-like growth factor-binding protein-5 (igfbp-5): implications for igf and igf-i receptor interactions |
|
7
|
32
|
1bzbA |
Glycosylated eel calcitonin |
|
1
|
10
|
1c98A |
Solution structure of neuromedin b |
|
11
|
39
|
1jrjA |
Solution structure of exendin-4 in 30-vol% trifluoroethanol |
|
6
|
30
|
4aiyB |
R6 human insulin hexamer (symmetric), nmr, 'green' substate, average structure |
|
3
|
21
|
4aiyA |
R6 human insulin hexamer (symmetric), nmr, 'green' substate, average structure |
|
0
|
11
|
1xy9A |
Nmr strcutre of sst1-selective somatostatin (srif) analog 1 |
|
75
|
299
|
5nwzA |
Fibroblast growth factor receptor 4 kinase domain (449-753) in complex with irreversible ligand cga159527 |
|
86
|
301
|
5nudA |
Fibroblast growth factor receptor 4 kinase domain (449-753) in complex with irreversible ligand cga159527 |
|
5
|
21
|
5aiyA |
R6 human insulin hexamer (symmetric), nmr, 'red' substate, average structure |
|
7
|
30
|
5aiyB |
R6 human insulin hexamer (symmetric), nmr, 'red' substate, average structure |
|
8
|
67
|
3bk3C |
Crystal structure of the complex of bmp-2 and the first von willebrand domain type c of crossveinless-2 |
|
17
|
104
|
3bk3A |
Crystal structure of the complex of bmp-2 and the first von willebrand domain type c of crossveinless-2 |
|
7
|
30
|
3aiyB |
R6 human insulin hexamer (symmetric), nmr, refined average structure |
|
4
|
21
|
3aiyA |
R6 human insulin hexamer (symmetric), nmr, refined average structure |
|
26
|
115
|
2qgdA |
Human transthyretin (ttr) complexed with 2-(3,5-dibromo-4-hydroxyphenyl)benzoxazole |
|
28
|
115
|
2qgeA |
Human transthyretin (ttr) complexed with 2-(3,5-dimethylphenyl)benzoxazole |
|
26
|
115
|
2qgcA |
Human transthyretin (ttr) complexed with 2-(3,5-dimethyl-4-hydroxyphenyl)benzoxazole |
|
29
|
115
|
2qgbA |
Human transthyretin (ttr) in apo-form |
